Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy

5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue barriers like stratum corneum (SC) of skin. Here, we aimed to develop 5-ALA loaded ultradeformable liposomes (UDL) with different surface charges,...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmaceutical sciences Vol. 44; no. 1; pp. 149 - 157
Main Authors Oh, Eun kyung, Jin, Su-Eon, Kim, Jin-Ki, Park, Jeong-Sook, Park, Youmie, Kim, Chong-Kook
Format Journal Article
LanguageEnglish
Published Kindlington Elsevier B.V 18.09.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue barriers like stratum corneum (SC) of skin. Here, we aimed to develop 5-ALA loaded ultradeformable liposomes (UDL) with different surface charges, and to investigate their physicochemical characteristics and capability for the skin penetration and retention of 5-ALA for topical photodynamic therapy (PDT). The effects of surface charges of UDL on in vitro permeation of 5-ALA and in vivo accumulation of 5-ALA−induced PpIX in viable skin were determined and then compared with conventional neutral liposomes (nLiposome). All UDL showed smaller particle size and better deformability than nLiposome. However, entrapment efficiency of 5-ALA was similar to each vesicle. Among vesicles, the cationic UDL (cUDL) demonstrated higher stability and permeability, and could deliver 5-ALA into deep skin tissue by topical application. Moreover, the 5-ALA loaded in cUDL was long retained, and induced more amount of PpIX in viable skin than those in other UDL and nLiposome. Considering that the conversion of 5-ALA into PpIX occurs preferentially in epidermis, these results suggested that topical delivery of 5-ALA loaded in cUDL could be an interesting proposal to optimize PDT related to 5-ALA.
AbstractList 5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue barriers like stratum corneum (SC) of skin. Here, we aimed to develop 5-ALA loaded ultradeformable liposomes (UDL) with different surface charges, and to investigate their physicochemical characteristics and capability for the skin penetration and retention of 5-ALA for topical photodynamic therapy (PDT). The effects of surface charges of UDL on in vitro permeation of 5-ALA and in vivo accumulation of 5-ALA-induced PpIX in viable skin were determined and then compared with conventional neutral liposomes (nLiposome). All UDL showed smaller particle size and better deformability than nLiposome. However, entrapment efficiency of 5-ALA was similar to each vesicle. Among vesicles, the cationic UDL (cUDL) demonstrated higher stability and permeability, and could deliver 5-ALA into deep skin tissue by topical application. Moreover, the 5-ALA loaded in cUDL was long retained, and induced more amount of PpIX in viable skin than those in other UDL and nLiposome. Considering that the conversion of 5-ALA into PpIX occurs preferentially in epidermis, these results suggested that topical delivery of 5-ALA loaded in cUDL could be an interesting proposal to optimize PDT related to 5-ALA.
5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue barriers like stratum corneum (SC) of skin. Here, we aimed to develop 5-ALA loaded ultradeformable liposomes (UDL) with different surface charges, and to investigate their physicochemical characteristics and capability for the skin penetration and retention of 5-ALA for topical photodynamic therapy (PDT). The effects of surface charges of UDL on in vitro permeation of 5-ALA and in vivo accumulation of 5-ALA−induced PpIX in viable skin were determined and then compared with conventional neutral liposomes (nLiposome). All UDL showed smaller particle size and better deformability than nLiposome. However, entrapment efficiency of 5-ALA was similar to each vesicle. Among vesicles, the cationic UDL (cUDL) demonstrated higher stability and permeability, and could deliver 5-ALA into deep skin tissue by topical application. Moreover, the 5-ALA loaded in cUDL was long retained, and induced more amount of PpIX in viable skin than those in other UDL and nLiposome. Considering that the conversion of 5-ALA into PpIX occurs preferentially in epidermis, these results suggested that topical delivery of 5-ALA loaded in cUDL could be an interesting proposal to optimize PDT related to 5-ALA.
Author Kim, Jin-Ki
Kim, Chong-Kook
Jin, Su-Eon
Park, Jeong-Sook
Oh, Eun kyung
Park, Youmie
Author_xml – sequence: 1
  givenname: Eun kyung
  surname: Oh
  fullname: Oh, Eun kyung
  organization: College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea
– sequence: 2
  givenname: Su-Eon
  surname: Jin
  fullname: Jin, Su-Eon
  organization: College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea
– sequence: 3
  givenname: Jin-Ki
  surname: Kim
  fullname: Kim, Jin-Ki
  organization: College of Pharmacy, Hanyang University, Ansan Gyeonggi 426-791, Republic of Korea
– sequence: 4
  givenname: Jeong-Sook
  surname: Park
  fullname: Park, Jeong-Sook
  organization: College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon 305-764, Republic of Korea
– sequence: 5
  givenname: Youmie
  surname: Park
  fullname: Park, Youmie
  organization: College of Pharmacy, Inje University, Gimhae Gyungnam 621-749, Republic of Korea
– sequence: 6
  givenname: Chong-Kook
  surname: Kim
  fullname: Kim, Chong-Kook
  email: ckkim@inje.ac.kr, ckkim@plaza.snu.ac.kr, ckkim@snu.ac.kr
  organization: College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24488482$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21782942$$D View this record in MEDLINE/PubMed
BookMark eNp9kEGL1DAYhoOsuLOrf8CD5CKeWpNM2iTgRRbdFRYE0XNIk69uhjSpSTow_96WGfXm6YOX5335eG7QVUwREHpNSUsJ7d8fWjjMpWWE0paIlpD9M7SjUqiGCEau0I4oJhuipLhGN6UcCCG9FOQFumZUSKY426H6DarxERyuafbWBOwg-CPkE04j7hoz-ZgCHJfgo7fYWO_wUnz8ia2pPm3ZEmo2DsaUJzMEwMHPqaQJCl4jPD-lmtwprkMW1yfIZj69RM9HEwq8utxb9OPzp-93D83j1_svdx8fG8s7WhvX9dbRfjCcipEpZsGObnBO9gMRe6BuVNbaTlIhpOoN4YpzpQbBe04VQL-_Re_Ou3NOvxYoVU--WAjBREhL0VJyyTuh6EqyM2lzKiXDqOfsJ5NPmhK9ydYHvcnWm2xNhF5lr6U3l_llmMD9rfyxuwJvL4Apq9oxm2h9-cdxvn2wcR_OHKwyjh6yLtZDtOB8Blu1S_5_f_wGknSiEQ
CitedBy_id crossref_primary_10_3109_03639045_2016_1165691
crossref_primary_10_3390_ijms22189743
crossref_primary_10_1016_j_jconrel_2017_11_049
crossref_primary_10_1016_j_pdpdt_2017_08_011
crossref_primary_10_1039_D2NA00530A
crossref_primary_10_1021_acsami_9b04305
crossref_primary_10_1021_acs_molpharmaceut_7b00099
crossref_primary_10_1016_j_ijpharm_2015_08_036
crossref_primary_10_1002_anbr_202400003
crossref_primary_10_1021_acs_molpharmaceut_3c00494
crossref_primary_10_1080_17425247_2016_1206073
crossref_primary_10_1039_c3py00049d
crossref_primary_10_1080_10837450_2021_2004606
crossref_primary_10_1088_0957_4484_24_32_325101
crossref_primary_10_3390_molecules25215184
crossref_primary_10_4155_tde_2016_0093
crossref_primary_10_2174_1381612826666200826140448
crossref_primary_10_1016_j_jddst_2019_101329
crossref_primary_10_1517_17425247_2012_697894
crossref_primary_10_3390_pharmaceutics13010033
crossref_primary_10_1016_j_ajps_2013_07_016
crossref_primary_10_2174_1574885513666181112153213
crossref_primary_10_1080_10717544_2022_2108939
crossref_primary_10_2217_nnm_2021_0335
crossref_primary_10_3390_ph14080772
crossref_primary_10_1002_smll_201502131
crossref_primary_10_1016_j_colsurfb_2019_03_021
crossref_primary_10_2174_1389450122999210101230743
crossref_primary_10_1016_j_ejps_2015_12_003
crossref_primary_10_1186_s12951_023_01877_4
crossref_primary_10_1155_2014_895986
crossref_primary_10_1021_acsanm_2c01805
crossref_primary_10_1007_s00432_023_05429_z
crossref_primary_10_1016_j_xphs_2023_10_033
crossref_primary_10_1517_17425247_2013_779252
crossref_primary_10_1016_j_jddst_2015_04_009
crossref_primary_10_4155_tde_2017_0075
crossref_primary_10_1016_j_jddst_2022_103933
crossref_primary_10_53879_id_58_11_12216
crossref_primary_10_1016_j_drudis_2013_04_003
crossref_primary_10_1039_C5RA26737D
crossref_primary_10_1080_17425247_2024_2318460
crossref_primary_10_1371_journal_pone_0148850
crossref_primary_10_1016_j_neo_2022_100810
crossref_primary_10_1021_acsnano_8b03007
crossref_primary_10_1016_j_plipres_2016_08_005
crossref_primary_10_2174_0929867325666181116143713
crossref_primary_10_1016_j_jddst_2019_01_028
Cites_doi 10.1080/03639040500216170
10.1016/j.bbamem.2004.01.006
10.1081/DDC-120025458
10.1016/j.jconrel.2004.08.025
10.3109/10611860108995632
10.1016/j.ejpb.2005.01.011
10.3109/02652048.2010.507880
10.1016/S0142-9612(03)00534-9
10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O
10.1002/ijc.10802
10.1002/jgm.1268
10.1016/j.ijpharm.2010.06.034
10.1038/sj.bjc.6600144
10.1159/000018006
10.1186/1471-5945-1-5
10.1006/abio.2001.5338
10.1562/2004-08-23-IR-283R1.1
10.1016/j.biomaterials.2005.05.097
10.1016/j.ijpharm.2003.10.031
10.1016/S0378-5173(01)00832-8
10.1007/s11095-005-9261-x
10.1016/j.ejpb.2010.01.008
10.1016/j.jconrel.2008.10.003
10.1023/A:1007612905378
10.1016/S0928-0987(01)00167-1
10.1016/j.biomaterials.2004.02.020
10.1046/j.1365-2230.2002.01024.x
10.1038/sj.bjc.6690255
10.1016/j.jphotobiol.2010.06.012
10.1021/js980018w
10.1016/S0005-2736(02)00401-7
ContentType Journal Article
Copyright 2011 Elsevier B.V.
2015 INIST-CNRS
Copyright © 2011 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2011 Elsevier B.V.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 Elsevier B.V. All rights reserved.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ejps.2011.07.003
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1879-0720
EndPage 157
ExternalDocumentID 10_1016_j_ejps_2011_07_003
21782942
24488482
S0928098711002260
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
0SF
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HMT
HVGLF
HZ~
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OK1
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
TEORI
WUQ
~G-
ABPIF
ABPTK
IQODW
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ADVLN
CITATION
7X8
ID FETCH-LOGICAL-c451t-d56cd16ba417f292cecfdbdd86b073e1df9ccc58177896a0494499b746419ee63
IEDL.DBID .~1
ISSN 0928-0987
IngestDate Fri Oct 25 04:30:11 EDT 2024
Thu Sep 26 17:25:13 EDT 2024
Sat Sep 28 07:48:26 EDT 2024
Sun Oct 22 16:08:58 EDT 2023
Fri Feb 23 02:19:33 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords 5-Aminolevulinic acid
Ultradeformable liposome
Photodynamic therapy
Topical delivery
Local administration
Pharmaceutical technology
Treatment
Cationic liposome
Topical administration
Language English
License CC BY 4.0
Copyright © 2011 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c451t-d56cd16ba417f292cecfdbdd86b073e1df9ccc58177896a0494499b746419ee63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21782942
PQID 884845791
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_884845791
crossref_primary_10_1016_j_ejps_2011_07_003
pubmed_primary_21782942
pascalfrancis_primary_24488482
elsevier_sciencedirect_doi_10_1016_j_ejps_2011_07_003
PublicationCentury 2000
PublicationDate 2011-09-18
PublicationDateYYYYMMDD 2011-09-18
PublicationDate_xml – month: 09
  year: 2011
  text: 2011-09-18
  day: 18
PublicationDecade 2010
PublicationPlace Kindlington
PublicationPlace_xml – name: Kindlington
– name: Netherlands
PublicationTitle European journal of pharmaceutical sciences
PublicationTitleAlternate Eur J Pharm Sci
PublicationYear 2011
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Ogiso, Yamaguchi, Iwaki, Tanino, Miyake (b0115) 2001; 9
Kosobe, Moriyama, Tokuoka (b0085) 2005; 31
Cevc, Blume (b0030) 2004; 1663
Song, Kim (b0145) 2006; 27
De Rosa, Bentley (b0040) 2000; 17
Fritsch, Lehmann, Stahl, Schulte, Blohm, Lang, Sies, Ruzicka (b0055) 1999; 79
Merclin, Bender, Sparr, Guy, Ehrsson, Engstrom (b0100) 2004; 100
Cevc, Schatzlein, Richardsen (b0025) 2002; 1564
Pease, White, Basketter (b0120) 2002; 27
Pierre, Tedesco, Marchetti, Bentley (b0130) 2001; 1
Manosroi, Kongkaneramit, Manosroi (b0095) 2004; 270
Hurlimann, Hanggi, Panizzon (b0065) 1998; 197
Kim, Lee, Choi, Kim (b0075) 2004; 25
Peng, Warloe, Berg, Moan, Kongshaug, Giercksky, Nesland (b0125) 1997; 79
De Campos Araújo, Thomazine, Lopez (b0035) 2010; 75
Casas, Perotti, Saccoliti, Sacca, Fukuda, Batlle (b0020) 2002; 86
Donnelly, McCarron, Woolfson (b0045) 2005; 81
Morrow, McCarron, Woolfson, Juzenas, Juzeniene, Iani, Moan, Donnelly (b0110) 2010; 101
Jain, Jain, Umamaheshwari, Jain (b0070) 2003; 29
Sznitowska, Janicki, Williams (b0155) 1998; 87
Lee, Kim, Oh, Kim (b0090) 2005; 26
Pierre, Ricci, Tedesco, Bentley (b0135) 2006; 23
Barry (b0010) 2001; 14
Betz, Nowbakht, Imboden, Imanidis (b0015) 2001; 228
Moan, MA, Juzeniene, Iani, Juzenas, Apricena, Peng (b0105) 2003; 103
Steluti, De Rosa, Collett, Tedesco, Bentley (b0150) 2005; 60
Song, Hyun, Kim, Kim, Oh (b0140) 2011; 28
Kim, Lee, Park, Jin, Ahn, Kim (b0080) 2009; 11
Geusens, Lambert, De Smedt, Buyens, Sanders, Van Gele (b0060) 2009; 133
Bantan-Polak, Kassai, Grant (b0005) 2001; 297
El Zaafarany, Awadm, Holayel, Mortada (b0050) 2010; 397
Barry (10.1016/j.ejps.2011.07.003_b0010) 2001; 14
Geusens (10.1016/j.ejps.2011.07.003_b0060) 2009; 133
Manosroi (10.1016/j.ejps.2011.07.003_b0095) 2004; 270
Ogiso (10.1016/j.ejps.2011.07.003_b0115) 2001; 9
Pease (10.1016/j.ejps.2011.07.003_b0120) 2002; 27
El Zaafarany (10.1016/j.ejps.2011.07.003_b0050) 2010; 397
Peng (10.1016/j.ejps.2011.07.003_b0125) 1997; 79
Cevc (10.1016/j.ejps.2011.07.003_b0030) 2004; 1663
Jain (10.1016/j.ejps.2011.07.003_b0070) 2003; 29
Kosobe (10.1016/j.ejps.2011.07.003_b0085) 2005; 31
Song (10.1016/j.ejps.2011.07.003_b0140) 2011; 28
Morrow (10.1016/j.ejps.2011.07.003_b0110) 2010; 101
Steluti (10.1016/j.ejps.2011.07.003_b0150) 2005; 60
De Rosa (10.1016/j.ejps.2011.07.003_b0040) 2000; 17
Song (10.1016/j.ejps.2011.07.003_b0145) 2006; 27
Cevc (10.1016/j.ejps.2011.07.003_b0025) 2002; 1564
Moan (10.1016/j.ejps.2011.07.003_b0105) 2003; 103
Sznitowska (10.1016/j.ejps.2011.07.003_b0155) 1998; 87
Betz (10.1016/j.ejps.2011.07.003_b0015) 2001; 228
Pierre (10.1016/j.ejps.2011.07.003_b0130) 2001; 1
Kim (10.1016/j.ejps.2011.07.003_b0080) 2009; 11
De Campos Araújo (10.1016/j.ejps.2011.07.003_b0035) 2010; 75
Hurlimann (10.1016/j.ejps.2011.07.003_b0065) 1998; 197
Kim (10.1016/j.ejps.2011.07.003_b0075) 2004; 25
Casas (10.1016/j.ejps.2011.07.003_b0020) 2002; 86
Pierre (10.1016/j.ejps.2011.07.003_b0135) 2006; 23
Fritsch (10.1016/j.ejps.2011.07.003_b0055) 1999; 79
Merclin (10.1016/j.ejps.2011.07.003_b0100) 2004; 100
Bantan-Polak (10.1016/j.ejps.2011.07.003_b0005) 2001; 297
Donnelly (10.1016/j.ejps.2011.07.003_b0045) 2005; 81
Lee (10.1016/j.ejps.2011.07.003_b0090) 2005; 26
References_xml – volume: 103
  start-page: 132
  year: 2003
  end-page: 135
  ident: b0105
  article-title: Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters
  publication-title: Int. J. Cancer
  contributor:
    fullname: Peng
– volume: 297
  start-page: 128
  year: 2001
  end-page: 136
  ident: b0005
  article-title: A comparison of fluorescamine and naphthalene-2,3-dicarboxaldehyde fluorogenic reagents for microplate-based detection of amino acids
  publication-title: Anal. Biochem.
  contributor:
    fullname: Grant
– volume: 31
  start-page: 623
  year: 2005
  end-page: 629
  ident: b0085
  article-title: Size and surface charge effect of 5-aminolevulinic acid-containing liposomes on photodynamic therapy for cultivated cancer cells
  publication-title: Drug Dev. Ind. Pharm.
  contributor:
    fullname: Tokuoka
– volume: 100
  start-page: 191
  year: 2004
  end-page: 198
  ident: b0100
  article-title: Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester
  publication-title: J. Control. Release
  contributor:
    fullname: Engstrom
– volume: 26
  start-page: 205
  year: 2005
  end-page: 210
  ident: b0090
  article-title: Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes
  publication-title: Biomaterials
  contributor:
    fullname: Kim
– volume: 11
  start-page: 26
  year: 2009
  end-page: 37
  ident: b0080
  article-title: Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis
  publication-title: J. Gene Med.
  contributor:
    fullname: Kim
– volume: 14
  start-page: 101
  year: 2001
  end-page: 114
  ident: b0010
  article-title: Novel mechanisms and devices to enable successful transdermal drug delivery
  publication-title: Eur. J. Pharm. Sci.
  contributor:
    fullname: Barry
– volume: 17
  start-page: 1447
  year: 2000
  end-page: 1455
  ident: b0040
  article-title: Photodynamic therapy of skin cancers: sensitizers, clinical studies and future
  publication-title: Pharm. Res.
  contributor:
    fullname: Bentley
– volume: 270
  start-page: 279
  year: 2004
  end-page: 286
  ident: b0095
  article-title: Stability and transdermal absorption of topical amphotericin B liposome formulations
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Manosroi
– volume: 28
  start-page: 151
  year: 2011
  end-page: 158
  ident: b0140
  article-title: Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes
  publication-title: J. Microencap.
  contributor:
    fullname: Oh
– volume: 197
  start-page: 248
  year: 1998
  end-page: 254
  ident: b0065
  article-title: Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion
  publication-title: Dermatology
  contributor:
    fullname: Panizzon
– volume: 228
  start-page: 147
  year: 2001
  end-page: 159
  ident: b0015
  article-title: Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Imanidis
– volume: 75
  start-page: 48
  year: 2010
  end-page: 55
  ident: b0035
  article-title: Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Lopez
– volume: 1564
  start-page: 21
  year: 2002
  end-page: 30
  ident: b0025
  article-title: Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurement
  publication-title: Biochim Biophy Acta
  contributor:
    fullname: Richardsen
– volume: 23
  start-page: 360
  year: 2006
  end-page: 366
  ident: b0135
  article-title: Oleic acid as Optimizer of the skin delivery of 5-aminolevulinic acid photodynamic therapy
  publication-title: Pharm. Res.
  contributor:
    fullname: Bentley
– volume: 29
  start-page: 1013
  year: 2003
  end-page: 1026
  ident: b0070
  article-title: Transfersomes–a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation
  publication-title: Drug Dev. Ind. Pharm.
  contributor:
    fullname: Jain
– volume: 1
  start-page: 5
  year: 2001
  ident: b0130
  article-title: Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study
  publication-title: BMC Dermatol.
  contributor:
    fullname: Bentley
– volume: 1663
  start-page: 61
  year: 2004
  end-page: 73
  ident: b0030
  article-title: Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Blume
– volume: 60
  start-page: 439
  year: 2005
  end-page: 444
  ident: b0150
  article-title: Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Bentley
– volume: 27
  start-page: 296
  year: 2002
  end-page: 300
  ident: b0120
  article-title: Skin as a route of exposure to protein allergens
  publication-title: Clin. Exp. Dermatol.
  contributor:
    fullname: Basketter
– volume: 25
  start-page: 305
  year: 2004
  end-page: 313
  ident: b0075
  article-title: In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome
  publication-title: Biomaterials
  contributor:
    fullname: Kim
– volume: 27
  start-page: 271
  year: 2006
  end-page: 280
  ident: b0145
  article-title: Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes
  publication-title: Biomaterials
  contributor:
    fullname: Kim
– volume: 81
  start-page: 750
  year: 2005
  end-page: 767
  ident: b0045
  article-title: Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy
  publication-title: Photochem. Photobiol.
  contributor:
    fullname: Woolfson
– volume: 133
  start-page: 214
  year: 2009
  end-page: 220
  ident: b0060
  article-title: Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes
  publication-title: J. Control. Release
  contributor:
    fullname: Van Gele
– volume: 101
  start-page: 59
  year: 2010
  end-page: 69
  ident: b0110
  article-title: Novel patch-based systems for the localized delivery of ALA-esters
  publication-title: J. Photochem. Photobiol. B
  contributor:
    fullname: Donnelly
– volume: 9
  start-page: 49
  year: 2001
  end-page: 59
  ident: b0115
  article-title: Effect of positively and negatively charged liposomes on skin permeation of drugs
  publication-title: J. Drug Target.
  contributor:
    fullname: Miyake
– volume: 397
  start-page: 164
  year: 2010
  end-page: 172
  ident: b0050
  article-title: Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Mortada
– volume: 86
  start-page: 837
  year: 2002
  end-page: 842
  ident: b0020
  article-title: ALA and ALA hexyl ester in free and liposomal formulations for the photosensitization of tumour organ cultures
  publication-title: Br. J. Cancer
  contributor:
    fullname: Batlle
– volume: 79
  start-page: 1603
  year: 1999
  end-page: 1608
  ident: b0055
  article-title: Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid
  publication-title: Br. J. Cancer
  contributor:
    fullname: Ruzicka
– volume: 87
  start-page: 1109
  year: 1998
  end-page: 1113
  ident: b0155
  article-title: Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum
  publication-title: J. Pharm. Sci.
  contributor:
    fullname: Williams
– volume: 79
  start-page: 2282
  year: 1997
  end-page: 2308
  ident: b0125
  article-title: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges
  publication-title: Cancer
  contributor:
    fullname: Nesland
– volume: 31
  start-page: 623
  year: 2005
  ident: 10.1016/j.ejps.2011.07.003_b0085
  article-title: Size and surface charge effect of 5-aminolevulinic acid-containing liposomes on photodynamic therapy for cultivated cancer cells
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.1080/03639040500216170
  contributor:
    fullname: Kosobe
– volume: 1663
  start-page: 61
  year: 2004
  ident: 10.1016/j.ejps.2011.07.003_b0030
  article-title: Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamem.2004.01.006
  contributor:
    fullname: Cevc
– volume: 29
  start-page: 1013
  year: 2003
  ident: 10.1016/j.ejps.2011.07.003_b0070
  article-title: Transfersomes–a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.1081/DDC-120025458
  contributor:
    fullname: Jain
– volume: 100
  start-page: 191
  year: 2004
  ident: 10.1016/j.ejps.2011.07.003_b0100
  article-title: Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2004.08.025
  contributor:
    fullname: Merclin
– volume: 9
  start-page: 49
  year: 2001
  ident: 10.1016/j.ejps.2011.07.003_b0115
  article-title: Effect of positively and negatively charged liposomes on skin permeation of drugs
  publication-title: J. Drug Target.
  doi: 10.3109/10611860108995632
  contributor:
    fullname: Ogiso
– volume: 60
  start-page: 439
  year: 2005
  ident: 10.1016/j.ejps.2011.07.003_b0150
  article-title: Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2005.01.011
  contributor:
    fullname: Steluti
– volume: 28
  start-page: 151
  year: 2011
  ident: 10.1016/j.ejps.2011.07.003_b0140
  article-title: Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes
  publication-title: J. Microencap.
  doi: 10.3109/02652048.2010.507880
  contributor:
    fullname: Song
– volume: 25
  start-page: 305
  year: 2004
  ident: 10.1016/j.ejps.2011.07.003_b0075
  article-title: In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome
  publication-title: Biomaterials
  doi: 10.1016/S0142-9612(03)00534-9
  contributor:
    fullname: Kim
– volume: 79
  start-page: 2282
  year: 1997
  ident: 10.1016/j.ejps.2011.07.003_b0125
  article-title: 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O
  contributor:
    fullname: Peng
– volume: 103
  start-page: 132
  year: 2003
  ident: 10.1016/j.ejps.2011.07.003_b0105
  article-title: Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.10802
  contributor:
    fullname: Moan
– volume: 11
  start-page: 26
  year: 2009
  ident: 10.1016/j.ejps.2011.07.003_b0080
  article-title: Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis
  publication-title: J. Gene Med.
  doi: 10.1002/jgm.1268
  contributor:
    fullname: Kim
– volume: 397
  start-page: 164
  year: 2010
  ident: 10.1016/j.ejps.2011.07.003_b0050
  article-title: Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2010.06.034
  contributor:
    fullname: El Zaafarany
– volume: 86
  start-page: 837
  year: 2002
  ident: 10.1016/j.ejps.2011.07.003_b0020
  article-title: ALA and ALA hexyl ester in free and liposomal formulations for the photosensitization of tumour organ cultures
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6600144
  contributor:
    fullname: Casas
– volume: 197
  start-page: 248
  year: 1998
  ident: 10.1016/j.ejps.2011.07.003_b0065
  article-title: Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion
  publication-title: Dermatology
  doi: 10.1159/000018006
  contributor:
    fullname: Hurlimann
– volume: 1
  start-page: 5
  year: 2001
  ident: 10.1016/j.ejps.2011.07.003_b0130
  article-title: Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study
  publication-title: BMC Dermatol.
  doi: 10.1186/1471-5945-1-5
  contributor:
    fullname: Pierre
– volume: 297
  start-page: 128
  year: 2001
  ident: 10.1016/j.ejps.2011.07.003_b0005
  article-title: A comparison of fluorescamine and naphthalene-2,3-dicarboxaldehyde fluorogenic reagents for microplate-based detection of amino acids
  publication-title: Anal. Biochem.
  doi: 10.1006/abio.2001.5338
  contributor:
    fullname: Bantan-Polak
– volume: 81
  start-page: 750
  year: 2005
  ident: 10.1016/j.ejps.2011.07.003_b0045
  article-title: Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy
  publication-title: Photochem. Photobiol.
  doi: 10.1562/2004-08-23-IR-283R1.1
  contributor:
    fullname: Donnelly
– volume: 27
  start-page: 271
  year: 2006
  ident: 10.1016/j.ejps.2011.07.003_b0145
  article-title: Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2005.05.097
  contributor:
    fullname: Song
– volume: 270
  start-page: 279
  year: 2004
  ident: 10.1016/j.ejps.2011.07.003_b0095
  article-title: Stability and transdermal absorption of topical amphotericin B liposome formulations
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2003.10.031
  contributor:
    fullname: Manosroi
– volume: 228
  start-page: 147
  year: 2001
  ident: 10.1016/j.ejps.2011.07.003_b0015
  article-title: Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(01)00832-8
  contributor:
    fullname: Betz
– volume: 23
  start-page: 360
  year: 2006
  ident: 10.1016/j.ejps.2011.07.003_b0135
  article-title: Oleic acid as Optimizer of the skin delivery of 5-aminolevulinic acid photodynamic therapy
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-005-9261-x
  contributor:
    fullname: Pierre
– volume: 75
  start-page: 48
  year: 2010
  ident: 10.1016/j.ejps.2011.07.003_b0035
  article-title: Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2010.01.008
  contributor:
    fullname: De Campos Araújo
– volume: 133
  start-page: 214
  year: 2009
  ident: 10.1016/j.ejps.2011.07.003_b0060
  article-title: Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2008.10.003
  contributor:
    fullname: Geusens
– volume: 17
  start-page: 1447
  year: 2000
  ident: 10.1016/j.ejps.2011.07.003_b0040
  article-title: Photodynamic therapy of skin cancers: sensitizers, clinical studies and future
  publication-title: Pharm. Res.
  doi: 10.1023/A:1007612905378
  contributor:
    fullname: De Rosa
– volume: 14
  start-page: 101
  year: 2001
  ident: 10.1016/j.ejps.2011.07.003_b0010
  article-title: Novel mechanisms and devices to enable successful transdermal drug delivery
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/S0928-0987(01)00167-1
  contributor:
    fullname: Barry
– volume: 26
  start-page: 205
  year: 2005
  ident: 10.1016/j.ejps.2011.07.003_b0090
  article-title: Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2004.02.020
  contributor:
    fullname: Lee
– volume: 27
  start-page: 296
  year: 2002
  ident: 10.1016/j.ejps.2011.07.003_b0120
  article-title: Skin as a route of exposure to protein allergens
  publication-title: Clin. Exp. Dermatol.
  doi: 10.1046/j.1365-2230.2002.01024.x
  contributor:
    fullname: Pease
– volume: 79
  start-page: 1603
  year: 1999
  ident: 10.1016/j.ejps.2011.07.003_b0055
  article-title: Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6690255
  contributor:
    fullname: Fritsch
– volume: 101
  start-page: 59
  year: 2010
  ident: 10.1016/j.ejps.2011.07.003_b0110
  article-title: Novel patch-based systems for the localized delivery of ALA-esters
  publication-title: J. Photochem. Photobiol. B
  doi: 10.1016/j.jphotobiol.2010.06.012
  contributor:
    fullname: Morrow
– volume: 87
  start-page: 1109
  year: 1998
  ident: 10.1016/j.ejps.2011.07.003_b0155
  article-title: Intracellular or intercellular localization of the polar pathway of penetration across stratum corneum
  publication-title: J. Pharm. Sci.
  doi: 10.1021/js980018w
  contributor:
    fullname: Sznitowska
– volume: 1564
  start-page: 21
  year: 2002
  ident: 10.1016/j.ejps.2011.07.003_b0025
  article-title: Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurement
  publication-title: Biochim Biophy Acta
  doi: 10.1016/S0005-2736(02)00401-7
  contributor:
    fullname: Cevc
SSID ssj0006870
Score 2.2967887
Snippet 5-Aminolevulinic acid (5-ALA), inducing photodynamic protoporphyrin (PpIX), is a hydrophilic molecule, resulting in leashing the capacity to cross tissue...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 149
SubjectTerms 5-Aminolevulinic acid
Administration, Topical
Aminolevulinic Acid - administration & dosage
Aminolevulinic Acid - pharmacokinetics
Aminolevulinic Acid - therapeutic use
Animals
Biological and medical sciences
Cations
Drug Compounding
Drug Stability
General pharmacology
In Vitro Techniques
Liposomes
Male
Medical sciences
Mice
Mice, Hairless
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Photochemotherapy - methods
Photodynamic therapy
Photosensitizing Agents - administration & dosage
Photosensitizing Agents - pharmacokinetics
Photosensitizing Agents - therapeutic use
Protoporphyrins - biosynthesis
Skin - metabolism
Skin Absorption
Skin Diseases - drug therapy
Skin Diseases - metabolism
Surface Properties
Topical delivery
Ultradeformable liposome
Title Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy
URI https://dx.doi.org/10.1016/j.ejps.2011.07.003
https://www.ncbi.nlm.nih.gov/pubmed/21782942
https://search.proquest.com/docview/884845791
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqckFCiDfLY-UD6oWGzcN27GNVUS0gqgpaqbfIsR1IlcZRk0XaC7-dmThh1UM5cHXsJPJnz8Oeb4aQdwCxzEDPRSbNHZYwE5GuBGz3NGNxBfpZj-cdX0_F-oJ9vuSXe-R45sJgWOUk-4NMH6X11LKaZnPV1fXqe6xSGYPLjEnPwIhAv52B-oM1_eH3LsxDyLFgHHaOsPdEnAkxXu6q66c0npjJMLtLOT3odA9TVoVaF3cbo6NSOnlEHk7WJD0KP_yY7Ln2CTk4C-mot4f0fMeu6g_pAT3bJarePiXDN4wfBTlLB98hWNS6BuM0ttRXlEf6um59435tRvYk1aa2FOPkf9Bwzgdtm2a40daNlm_ZONrUne_9tespNNHupx-8DTXvaWB6bZ-Ri5OP58fraKrCEBnGkyGyXBibiFKzJK9SlRpnKltaK0UJ4sEltlLGGC6TPJdKaMw3A15UmTPBEuWcyJ6T_da37iXywzOQGYYroTLGS_DjY24c0o1ieGvGF-T9PP1FF5JtFHMU2lWBYBUIVhHjnXm2IHxGqLi1ZArQBv8ct7wF599PgaUjJZPpgtAZ3wI2G96g6Nb5TV_gY8ZzlSzIi4D7bnACtpZi6av__KvX5H44rlZRIt-Q_eFm496CvTOUy3FBL8m9o09f1qd_ABpkAWI
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQHFqpquh7S0t9qLiUaPOwHfuIUNFSYIXaReJmJbZDg0IckSzS_nvGccKKAxy4OnFi-bNnvrHngdBPgJgnoOcCFafGlTBjQVYw2O5xQsIC9HPWn3eczdnsgvy5pJcb6HCMhXFulYPs9zK9l9ZDy3SYzWlTltN_oYh5CCazS3oGJALs9i1gAwJ259bB8cls_iCQGe9rxrn3A9dhiJ3xbl7mummHTJ4umWHylH5602QtzFrhy108zUd7vXS0jd4OhBIf-DG_Qxumfo_2zn1G6tU-XqwDrNp9vIfP17mqVx9Q99e5kIKoxZ1tHF5Ym8q5aqywLTANspuytpW5W_YBlDhTpcbOVf4K-6M-aFtW3W2mTU9-88rgqmxsa29Mi6EJN_9tZ7Uve499sNfqI7o4-r04nAVDIYZAERp1gaZM6YjlGYnSIhaxMqrQudac5SAhTKQLoZSiPEpTLljmUs6AIZWnhJFIGMOST2iztrX54kLEExAbigomEkJzMOVDqoyLOArhqwmdoF_j9MvG59uQoyPatXRgSQeWDN21eTJBdERIPlo1EhTCs_12H8H58CsgO5wTHk8QHvGVsN_cJUpWG7tspXtMaCqiCfrscV93joBuCRJ_feGofqBXs8XZqTw9np_soNf-9FoEEf-GNrvbpfkO9KfLd4flfQ_m4AQW
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retained+topical+delivery+of+5-aminolevulinic+acid+using+cationic+ultradeformable+liposomes+for+photodynamic+therapy&rft.jtitle=European+journal+of+pharmaceutical+sciences&rft.au=Oh%2C+Eun+Kyung&rft.au=Jin%2C+Su-Eon&rft.au=Kim%2C+Jin-Ki&rft.au=Park%2C+Jeong-Sook&rft.date=2011-09-18&rft.eissn=1879-0720&rft.volume=44&rft.issue=1-2&rft.spage=149&rft.epage=157&rft_id=info:doi/10.1016%2Fj.ejps.2011.07.003&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0928-0987&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0928-0987&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0928-0987&client=summon